277 related articles for article (PubMed ID: 33154348)
1. Corticotropin releasing hormone receptor CRHR1 gene is associated with tianeptine antidepressant response in a large sample of outpatients from real-life settings.
Ramoz N; Hoertel N; Nobile B; Voegeli G; Nasr A; Le Strat Y; Courtet P; Gorwood P
Transl Psychiatry; 2020 Nov; 10(1):378. PubMed ID: 33154348
[TBL] [Abstract][Full Text] [Related]
2. Association study of corticotropin-releasing hormone receptor1 gene polymorphisms and antidepressant response in major depressive disorders.
Liu Z; Zhu F; Wang G; Xiao Z; Tang J; Liu W; Wang H; Liu H; Wang X; Wu Y; Cao Z; Li W
Neurosci Lett; 2007 Mar; 414(2):155-8. PubMed ID: 17258395
[TBL] [Abstract][Full Text] [Related]
3. Long-term voluntary exercise and the mouse hypothalamic-pituitary-adrenocortical axis: impact of concurrent treatment with the antidepressant drug tianeptine.
Droste SK; Schweizer MC; Ulbricht S; Reul JM
J Neuroendocrinol; 2006 Dec; 18(12):915-25. PubMed ID: 17076767
[TBL] [Abstract][Full Text] [Related]
4. Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment.
Papiol S; Arias B; Gastó C; Gutiérrez B; Catalán R; Fañanás L
J Affect Disord; 2007 Dec; 104(1-3):83-90. PubMed ID: 17467808
[TBL] [Abstract][Full Text] [Related]
5. Influence of genetic polymorphisms involved in the hypothalamic-pituitary-adrenal axis and their interactions with environmental factors on antidepressant response.
Geng LY; Ye DQ; Shi YY; Xu Z; Pu MJ; Li ZY; Li XL; Li Y; Zhang ZJ
CNS Neurosci Ther; 2014 Mar; 20(3):237-43. PubMed ID: 24422887
[TBL] [Abstract][Full Text] [Related]
6. Association analysis for corticotropin releasing hormone polymorphisms with the risk of major depressive disorder and the response to antidepressants.
Chang HS; Won E; Lee HY; Ham BJ; Lee MS
Behav Brain Res; 2015 Oct; 292():116-24. PubMed ID: 26055202
[TBL] [Abstract][Full Text] [Related]
7. Blunted HPA axis reactivity reveals glucocorticoid system dysbalance in a mouse model of high anxiety-related behavior.
Sotnikov S; Wittmann A; Bunck M; Bauer S; Deussing J; Schmidt M; Touma C; Landgraf R; Czibere L
Psychoneuroendocrinology; 2014 Oct; 48():41-51. PubMed ID: 24995583
[TBL] [Abstract][Full Text] [Related]
8. Relationship of cortisol levels and genetic polymorphisms to antidepressant response to placebo and fluoxetine in patients with major depressive disorder: a prospective study.
Ventura-Juncá R; Symon A; López P; Fiedler JL; Rojas G; Heskia C; Lara P; Marín F; Guajardo V; Araya AV; Sasso J; Herrera L
BMC Psychiatry; 2014 Aug; 14():220. PubMed ID: 25086452
[TBL] [Abstract][Full Text] [Related]
9. Interaction of childhood maltreatment with the corticotropin-releasing hormone receptor gene: effects on hypothalamic-pituitary-adrenal axis reactivity.
Tyrka AR; Price LH; Gelernter J; Schepker C; Anderson GM; Carpenter LL
Biol Psychiatry; 2009 Oct; 66(7):681-5. PubMed ID: 19596121
[TBL] [Abstract][Full Text] [Related]
10. Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans.
Licinio J; O'Kirwan F; Irizarry K; Merriman B; Thakur S; Jepson R; Lake S; Tantisira KG; Weiss ST; Wong ML
Mol Psychiatry; 2004 Dec; 9(12):1075-82. PubMed ID: 15365580
[TBL] [Abstract][Full Text] [Related]
11. PCLO rs2522833 modulates HPA system response to antidepressant treatment in major depressive disorder.
Schuhmacher A; Mössner R; Höfels S; Pfeiffer U; Guttenthaler V; Wagner M; Schwab SG; Maier W; Zobel A
Int J Neuropsychopharmacol; 2011 Mar; 14(2):237-45. PubMed ID: 20701824
[TBL] [Abstract][Full Text] [Related]
12. Corticotropin-releasing hormone system polymorphisms are associated with children's cortisol reactivity.
Sheikh HI; Kryski KR; Smith HJ; Hayden EP; Singh SM
Neuroscience; 2013 Jan; 229():1-11. PubMed ID: 23131710
[TBL] [Abstract][Full Text] [Related]
13. Gender-specific association of galanin polymorphisms with HPA-axis dysregulation, symptom severity, and antidepressant treatment response.
Unschuld PG; Ising M; Roeske D; Erhardt A; Specht M; Kloiber S; Uhr M; Müller-Myhsok B; Holsboer F; Binder EB
Neuropsychopharmacology; 2010 Jun; 35(7):1583-92. PubMed ID: 20237460
[TBL] [Abstract][Full Text] [Related]
14. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
Binder EB; Künzel HE; Nickel T; Kern N; Pfennig A; Majer M; Uhr M; Ising M; Holsboer F
Psychoneuroendocrinology; 2009 Jan; 34(1):99-109. PubMed ID: 18829172
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in the BDNF and BDNFOS genes are associated with hypothalamus-pituitary axis regulation in major depression.
Hennings JM; Kohli MA; Uhr M; Holsboer F; Ising M; Lucae S
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109686. PubMed ID: 31295515
[TBL] [Abstract][Full Text] [Related]
16. Effect of chronic treatment with the antidepressant tianeptine on the hypothalamo-pituitary-adrenal axis.
Delbende C; Tranchand Bunel D; Tarozzo G; Grino M; Oliver C; Mocaër E; Vaudry H
Eur J Pharmacol; 1994 Jan; 251(2-3):245-51. PubMed ID: 8149980
[TBL] [Abstract][Full Text] [Related]
17. Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress.
Müller MB; Zimmermann S; Sillaber I; Hagemeyer TP; Deussing JM; Timpl P; Kormann MS; Droste SK; Kühn R; Reul JM; Holsboer F; Wurst W
Nat Neurosci; 2003 Oct; 6(10):1100-7. PubMed ID: 12973355
[TBL] [Abstract][Full Text] [Related]
18. Allelic variation in CRHR1 predisposes to panic disorder: evidence for biased fear processing.
Weber H; Richter J; Straube B; Lueken U; Domschke K; Schartner C; Klauke B; Baumann C; Pané-Farré C; Jacob CP; Scholz CJ; Zwanzger P; Lang T; Fehm L; Jansen A; Konrad C; Fydrich T; Wittmann A; Pfleiderer B; Ströhle A; Gerlach AL; Alpers GW; Arolt V; Pauli P; Wittchen HU; Kent L; Hamm A; Kircher T; Deckert J; Reif A
Mol Psychiatry; 2016 Jun; 21(6):813-22. PubMed ID: 26324098
[TBL] [Abstract][Full Text] [Related]
19. Novel corticotropin-releasing hormone receptor genes (CRHR1 and CRHR2) linkage to and association with polycystic ovary syndrome.
Amin M; Horst N; Wu R; Gragnoli C
J Ovarian Res; 2023 Aug; 16(1):155. PubMed ID: 37543650
[TBL] [Abstract][Full Text] [Related]
20. Effects of escitalopram/quetiapine combination therapy versus escitalopram monotherapy on hypothalamic-pituitary-adrenal-axis activity in relation to antidepressant effectiveness.
Nothdurfter C; Schmotz C; Sarubin N; Baghai TC; Laenger A; Lieb M; Bondy B; Rupprecht R; Schüle C
J Psychiatr Res; 2014 May; 52():15-20. PubMed ID: 24513501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
